Business
ROCKWELL MEDICAL, INC.: BUSINESS OVERVIEW Rockwell Medical is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide.
Net income decreased 1007.1% to ($5.3M), while Operating cash flow decreased 115.7% to ($659.0K).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue N/AWatch
- Profitability — Net income ($5.3M)Watch
- Cash generation — Free cash flow ($1.2M)Note
- Accounting — No applicable forensic screenNote
- Insiders — 0 buys; 7 sells in 365 daysNote
- Capital — Comparable payout data unavailableNote
Where the revenue comes from
Fiscal 2025, as ROCKWELL MEDICAL, INC. reports it. History and quarterly detail are in the app.
- Concentrate Products Sales$68.9M
- License Fees$325K
Leadership changes
From ROCKWELL MEDICAL, INC.'s own filings, the day they're filed.
- Joseph H. Dawson · director · appointmenteff. 2025-11-17
- Andrea Heslin Smiley · Directors · departureeff. 2025-11-17
- Heather Hunter · President · appointmenteff. 2025-09-23
Latest filings
- 8-K · Company announcement2026-08-13
- 8-K · Company announcement2026-08-13
- 10-Q · Quarterly report2026-08-13
- 8-K · Company announcement2026-07-20
- 8-K · Company announcement2026-06-29
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about ROCKWELL MEDICAL, INC., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.